Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Pulmicort in African American Asthma Patients
NCT00702325Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in 1 Second at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00702325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702325.